Mark Gelder
Nessuna posizione attualmente
Profilo
Mark Stephen Gelder worked as an Executive Medical Director, Chief Medical Officer, Vice President of Medical Affairs & Oncology, and Vice President of Clinical Development in various pharmaceutical companies such as Labcorp Drug Development, Heron Therapeutics, Onconova Therapeutics, Accelovance, and Inovio Pharmaceuticals.
He also served as the Chief Medical Officer at Elevar Therapeutics and Pierian Biosciences LLC.
Gelder completed his undergraduate degree at Colgate University and earned his doctorate from The University of Virginia School of Medicine.
Precedenti posizioni note di Mark Gelder
Società | Posizione | Fine |
---|---|---|
TRAWS PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 06/04/2023 |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Corporate Officer/Principal | 01/06/2021 |
COVANCE INC. | Corporate Officer/Principal | 01/05/2020 |
HERON THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 23/01/2015 |
Pierian Biosciences LLC
Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Pierian Biosciences LLC operates as a diagnostic development and laboratory service company. It offers ChemoINTEL, a functional multi-parametric chemosensitivity assay measuring the real-time kinetic molecular and morphologic apoptotic response in isolated tumor cells; and ImmunoINTEL, a flow cytometry-based platform delivering phenotypic characterization and quantitative functional interrogation of tumor and immune populations within a tumor sample and relevant tissues. The company is headquartered in Franklin, TN. | Corporate Officer/Principal | - |
Formazione di Mark Gelder
Colgate University | Undergraduate Degree |
The University of Virginia School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
HERON THERAPEUTICS, INC. | Health Technology |
INOVIO PHARMACEUTICALS, INC. | Health Technology |
TRAWS PHARMA, INC. | Health Technology |
Aziende private | 4 |
---|---|
Accelovance, Inc.
Accelovance, Inc. Miscellaneous Commercial ServicesCommercial Services Accevolance, Inc. engages in providing clinical research and development services. It operates through the following core service divisions: Full-Service CRO, Patient Recruitment, and Clinical Call Center. The Full-Service CRO division includes protocol development, project management, clinical trial monitoring, data management, Biostatistics, Pharmacovigilance, regulatory affairs, and medical writing. The Patient Recruitment division involves patient recruitment and management. The Clinical Call Center division provides recruitment, retention, and compliance; post approval safety studies; Phase IV studies; surveillance programs; patient-reported outcomes; observational studies; registries; site support services; patient market research; and risk management support. The company was founded by Stephen J. Trevisan in 2005 and is headquartered in Rockville, MD. | Commercial Services |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
Pierian Biosciences LLC
Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Pierian Biosciences LLC operates as a diagnostic development and laboratory service company. It offers ChemoINTEL, a functional multi-parametric chemosensitivity assay measuring the real-time kinetic molecular and morphologic apoptotic response in isolated tumor cells; and ImmunoINTEL, a flow cytometry-based platform delivering phenotypic characterization and quantitative functional interrogation of tumor and immune populations within a tumor sample and relevant tissues. The company is headquartered in Franklin, TN. | Health Services |
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Borsa valori
- Insiders
- Mark Gelder